Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Centogene N.V. (NQ: CNTG ) 0.3479 -0.0291 (-7.72%) Streaming Delayed Price Updated: 1:03 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 78,646 Open 0.3504 Bid (Size) 0.3450 (129) Ask (Size) 0.3479 (4) Prev. Close 0.3770 Today's Range 0.3299 - 0.3730 52wk Range 0.3400 - 1.530 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development June 20, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting May 31, 2024 From Centogene NV Via GlobeNewswire Performance YTD -70.26% -70.26% 1 Month -11.92% -11.92% 3 Month -24.53% -24.53% 6 Month -71.01% -71.01% 1 Year -66.87% -66.87% More News Read More Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 16, 2024 Via InvestorPlace CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights May 15, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position May 15, 2024 From Centogene NV Via GlobeNewswire CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease May 14, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients May 10, 2024 From Centogene NV Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 19, 2024 Via InvestorPlace Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket April 19, 2024 Via Benzinga CENTOGENE Receives Nasdaq Non-Compliance Notice April 02, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders March 19, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency February 29, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing February 28, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Explores Strategic Alternatives February 28, 2024 From Centogene NV Via GlobeNewswire CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration January 25, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Receives French Research Tax Credit Accreditation January 24, 2024 From Centogene NV Via GlobeNewswire CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics January 23, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Announces Preliminary Full Year 2023 Revenue January 18, 2024 From Centogene NV Via GlobeNewswire CENTOGENE Announces Voting Results of Extraordinary General Meeting December 19, 2023 From Centogene NV Via GlobeNewswire CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone December 13, 2023 From Centogene NV Via GlobeNewswire CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction November 28, 2023 From Centogene NV Via GlobeNewswire CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism November 14, 2023 From Centogene NV Via GlobeNewswire CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering October 10, 2023 From Centogene NV Via GlobeNewswire CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11, 2023 From Centogene NV Via GlobeNewswire CENTOGENE Reports First Half 2023 Financial Results September 07, 2023 From Centogene NV Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
